News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
PUBLICATION

The neuropharmacological substrates of nicotine reward: reinforcing versus reinforcement-enhancing effects of nicotine.

June 29, 2009
Read More
PUBLICATION

Pharmacological characterization of harmaline-induced tremor activity in mice.

June 25, 2009
Read More
PUBLICATION

Systematic behavioral evaluation of Huntington’s disease transgenic and knock-in mouse models.

May 20, 2009
Read More
PUBLICATION

GABAa receptor α1 subunit (Gabra1) knockout mice: review and new results. In Mutant and Transgenic Tools in Modeling Brain Disorders

March 20, 2009
Read More
PUBLICATION

Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal bone development.

January 31, 2009
Read More
PUBLICATION

Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm.

December 12, 2008
Read More
PUBLICATION

Cognitive endpoints as disease biomarkers: optimizing the congruency of preclinical models to the clinic.

December 5, 2008
Read More
PUBLICATION

Learning and memory impairment in Eph receptor A6 knockout mice.

October 18, 2008
Read More
PUBLICATION

Interval timing in genetically modified mice: a simple paradigm.

August 26, 2008
Read More